HYPERLAB

High yield and performance stem cell lab

Coordinatore	FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V    more  Organization address address: Hansastrasse 27C city: MUENCHEN postcode: 80686 contact info Titolo: Ms. Nome: Andrea Cognome: Zeumann Email: send email Telefono: +49 89 1205 2723 Fax: +49 89 1205 77 2723
Nazionalità Coordinatore	Germany [DE]
Totale costo	3˙907˙456 €
EC contributo	2˙987˙601 €
Programma	FP7-HEALTH Specific Programme "Cooperation": Health
Code Call	FP7-HEALTH-2007-B
Funding Scheme	CP-FP
Anno di inizio	2009
Periodo (anno-mese-giorno)	2009-09-01   -   2012-08-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V  Organization address address: Hansastrasse 27C city: MUENCHEN postcode: 80686 contact info Titolo: Ms. Nome: Andrea Cognome: Zeumann Email: send email Telefono: +49 89 1205 2723 Fax: +49 89 1205 77 2723	DE (MUENCHEN)	coordinator	409˙610.47
2	KLINIKUM DER UNIVERSITAET ZU KOELN  Organization address address: Kerpener Strasse 62 city: KOELN postcode: 50937 contact info Titolo: Ms. Nome: Jutta Cognome: Landvogt Email: send email Telefono: 492215000000 Fax: 492215000000	DE (KOELN)	participant	460˙182.00
3	Nome Ente NON disponibile  Organization address address: Rosenhof 1 city: Heilbad Heiligenstadt postcode: 37308 contact info Titolo: Mr. Nome: Manfred Cognome: Meister Email: send email Telefono: +49 3606 671 120 Fax: +49 3606 671 200	DE (Heilbad Heiligenstadt)	participant	432˙644.00
4	INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA  Organization address address: Av. da Republica, Quinta do Marques S/N city: OEIRAS postcode: 2781901 contact info Titolo: Ms. Nome: Elsa Cognome: Vieira Email: send email Telefono: 351214000000 Fax: 351214000000	PT (OEIRAS)	participant	400˙200.00
5	MEDIZINISCHE UNIVERSITAET WIEN  Organization address address: SPITALGASSE 23 city: WIEN postcode: 1090 contact info Titolo: Prof. Nome: Peter Wolf Cognome: Husslein Email: send email Telefono: 431404000000 Fax: 431404000000	AT (WIEN)	participant	397˙245.00
6	TAKARA BIO EUROPE AB  Organization address address: ARVID WALLGRENS BACKE 20 city: GOETEBORG postcode: 413 46 contact info Titolo: Ms. Nome: Jenny Cognome: Goodwin Email: send email Telefono: +46 317580961 Fax: +46 317580910	SE (GOETEBORG)	participant	362˙575.00
7	ARTTIC  Organization address address: Rue du Dessous des Berges 58A city: PARIS postcode: 75013 contact info Titolo: Dr. Nome: Eric Cognome: Papon Email: send email Telefono: 33153945460 Fax: 33153945470	FR (PARIS)	participant	221˙046.00
8	CRYO-SAVE GROUP NV  Organization address address: IJsselkade 8 city: Zutphen postcode: 7201 hb contact info Titolo: Mr. Nome: Gilbert Cognome: Verhoef Email: send email Telefono: 0 Fax: 3215275145	NL (Zutphen)	participant	202˙722.53
9	UNIVERSIDAD CATOLICA DEL NORTE  Organization address address: AVENIDA ANGAMOS 0610 city: ANTOFAGASTA contact info Titolo: Mr. Nome: Luis Cognome: Moncayo Email: send email Telefono: 5651209716 Fax: 5651209750	CL (ANTOFAGASTA)	participant	101˙376.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'The success of stem cell therapy is highly dependent on a safe and reliable supply of human stem cells and stem cell-derived differentiated cells, which must be assured by efficient and robust culture methods. Current culture of human embryonic and adult stem cells is not optimised (with regards to e.g. media, growth factors, supporting biomaterials, differentiation techniques) and is far from fulfilling the demands in terms of reproducibility and preciseness. Additionally, current methods do not allow fast screening of culture conditions for their systematic optimisation. These limitations currently slow down the development of stem cell applications and will be addressed and overcome by the Hyperlab project. To reach the overall aim of developing new and improved culture methods, media and protocols for stem cell cultivation and differentiation, Hyperlab will adapt novel microfluidics-based cell cultivation technologies to the specific needs of stem cell culture. The developed culture systems will have two major advantages over existing approaches: on the one hand, they will improve stem cell culture in terms of microenvironment control, reproducibility, robustness and efficiency. On the other hand, these microscale technologies, together with developed transgenic readout systems, will allow medium to high throughput screening of culture conditions, enabling determination of optimal protocols in shorter time. Once established, technologies, protocols and conditions will be evaluated for their upscalability and will be made GMP-compliant to form a solid basis for progress in human stem cell therapy. To implement this innovative strategy, Hyperlab follows an integrated approach, bringing together renowned experts from stem cell biology, microsystem technologies, biomaterial design and relevant regulatory bodies. Hyperlab is thus in a position to provide standardised, reproducible methods and tools to advance therapeutic stem cell research.'

Introduzione (Teaser)

Stem cell-based therapies depend on robust supply of stem cells of adequate quality. The EU-funded HYPERLAB project developed new technologies for improved cultivation and differentiation of human stem cells.